These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The role of steroids and cytostatic drugs in the management of angioimmunoblastic lymphadenopathy]. Orv Hetil; 1984 Mar; 125(13):795-6. PubMed ID: 6709342 [No Abstract] [Full Text] [Related]
5. Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy). Knecht H; Schwarze EW; Lennert K Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):105-24. PubMed ID: 3922106 [TBL] [Abstract][Full Text] [Related]
6. [Local angioimmunoblastic lymphadenopathy (lymphogranulomatosis X). The position of angioimmunoblastic lymphadenopathy within the malignant lymphomas]. Hesselmann J Acta Med Austriaca; 1979; 6(5):241-4. PubMed ID: 555220 [TBL] [Abstract][Full Text] [Related]
8. [Immunoblastic lymphadenopathy. Experience in three cases (author's transl)]. Del Favero H; Grebe G; Lira P; Duarte I Sangre (Barc); 1979; 24(1):51-8. PubMed ID: 424973 [No Abstract] [Full Text] [Related]
9. [Blast transformation of malignant lymphoma]. Rupniewska ZM Pol Arch Med Wewn; 1980 Jun; 63(6):581-6. PubMed ID: 6995953 [No Abstract] [Full Text] [Related]
10. [History and clinical picture of lymphogranulomatosis X (including (angio)immunoblastic lymphadenopathy]. Knecht H; Lennert K Schweiz Med Wochenschr; 1981 Jul; 111(30):1108-21. PubMed ID: 7268365 [TBL] [Abstract][Full Text] [Related]
11. [Angioimmunoblastic lymphadenopathy and Hodgkin's disease]. Török I; Tiszai A; Boros I; Balázs L; Kelényi G Morphol Igazsagugyi Orv Sz; 1981 Apr; 21(2):107-12. PubMed ID: 7266539 [TBL] [Abstract][Full Text] [Related]
12. Malignant progression of angioimmunoblastic lymphadenopathy. Bamberg M; Donhuijsen K; Höher PG; Holfeld H; Hossfeld DK J Cancer Res Clin Oncol; 1979 Apr; 93(3):255-63. PubMed ID: 468887 [TBL] [Abstract][Full Text] [Related]
13. Suppressor T cell lymphoma with histological and clinical features of immunoblastic lymphadenopathy (IBL): IBL-like suppressor T cell lymphoma. Takeuchi Y; Yamamoto R; Nonaka Y; Saito Y; Ohta K; Sugimoto T Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):907-14. PubMed ID: 2945352 [No Abstract] [Full Text] [Related]
14. [Evolution of angioimmunoblastic lymphadenopathy to Hodgkin's disease. Description of 2 cases]. Trepińska E; Burian P Pol Arch Med Wewn; 1984 Jun; 71(6):389-95. PubMed ID: 6504712 [No Abstract] [Full Text] [Related]
15. [Case of immunoblastic lymphoma]. Gelenko AM Arkh Patol; 1979; 41(4):67-70. PubMed ID: 444093 [No Abstract] [Full Text] [Related]
16. Immunoblastic lymphadenopathy. A report of two cases. Kalus MJ Arch Pathol Lab Med; 1976 Sep; 100(9):465-8. PubMed ID: 988989 [TBL] [Abstract][Full Text] [Related]
17. [Clinical manifestations of the reactive immunoblastic proliferation of lymph nodes]. Zhang ZN; Liu TH; Liu EK Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):433-35. PubMed ID: 6242547 [No Abstract] [Full Text] [Related]
18. Immunoblastic lymphadenopathy: report of four new cases and review of the disease. Berris B; Fernandes B; Rother I Can Med Assoc J; 1982 Sep; 127(5):389-92. PubMed ID: 7104917 [No Abstract] [Full Text] [Related]